These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3873732

  • 21. Specificity and precursor frequency of cytotoxic T cells in the response to minor H antigens.
    Pilarski LM.
    Transplantation; 1986 Apr; 41(4):521-6. PubMed ID: 2938312
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
    Franksson L, Petersson M, Kiessling R, Kärre K.
    Eur J Immunol; 1993 Oct; 23(10):2606-13. PubMed ID: 8405061
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S.
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [Abstract] [Full Text] [Related]

  • 25. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T, Yoon JW, Park BJ, Imamura M, Averill N, Kawazu S, Santamaria P.
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G, Halloran PF.
    Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF, Green WR.
    J Immunol; 2002 Mar 15; 168(6):2751-8. PubMed ID: 11884442
    [Abstract] [Full Text] [Related]

  • 29. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y, Mayumi H, Eto M, Nomoto K.
    J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930
    [Abstract] [Full Text] [Related]

  • 30. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
    Huston DP, Tavana G, Rich RR, Gressens SE.
    J Immunol; 1986 Sep 15; 137(6):1776-81. PubMed ID: 2943800
    [Abstract] [Full Text] [Related]

  • 31. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
    De Waal LP, Melvold RW, Melief CJ.
    J Exp Med; 1983 Nov 01; 158(5):1537-46. PubMed ID: 6415206
    [Abstract] [Full Text] [Related]

  • 32. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR, Lyles DS, Parce JW.
    J Virol; 1987 Jun 01; 61(6):1992-8. PubMed ID: 3033326
    [Abstract] [Full Text] [Related]

  • 33. Class I restricted interaction between suppressor and cytolytic cells in the response to minor histocompatibility antigens.
    Rammensee HG, Juretic A, Nagy ZA, Klein J.
    J Immunol; 1984 Feb 01; 132(2):668-72. PubMed ID: 6197473
    [Abstract] [Full Text] [Related]

  • 34. Role of major and minor histocompatibility antigens in the suppression of alloreactive cytotoxic responses induced by alloantigen pretreatment.
    Przewlocki G, Leclerc C.
    Res Immunol; 1990 Feb 01; 141(9):839-53. PubMed ID: 1712502
    [Abstract] [Full Text] [Related]

  • 35. Pretreatment with minor histocompatibility antigens prevents the development of functional CTL helper cell activity.
    Hayes RL, Claman HN.
    J Immunol; 1983 Jan 01; 130(1):56-62. PubMed ID: 6216288
    [Abstract] [Full Text] [Related]

  • 36. Failure of a tumour to prime CTL specific for some of the minor H antigens it expresses but not others.
    Johnson LL.
    Immunology; 1991 Apr 01; 72(4):532-6. PubMed ID: 1903766
    [Abstract] [Full Text] [Related]

  • 37. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells.
    Forman J, Trial J, Tonkonogy S, Flaherty L.
    J Exp Med; 1982 Mar 01; 155(3):749-67. PubMed ID: 6174664
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic T-lymphocyte tolerance to minor H-43a alloantigen is induced exclusively in the context of the self major histocompatibility complex class I H-2Kb molecules.
    Ishikawa H, Hino T, Kato H, Suzuki H, Saito K.
    Cell Immunol; 1987 Dec 01; 110(2):436-42. PubMed ID: 3500797
    [Abstract] [Full Text] [Related]

  • 39. Helper T cells for cytotoxic T lymphocytes need not be I region restricted.
    Raulet DH, Bevan MJ.
    J Exp Med; 1982 Jun 01; 155(6):1766-84. PubMed ID: 6176668
    [Abstract] [Full Text] [Related]

  • 40. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M, Shimizu J, Tsuchida T, Takai Y, Fujiwara H, Hamaoka T.
    J Immunol; 1986 Feb 15; 136(4):1178-85. PubMed ID: 2935573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.